173 related articles for article (PubMed ID: 21804443)
1. Association between donor-specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation.
Tsai HL; Island ER; Chang JW; Gonzalez-Pinto I; Tryphonopoulos P; Nishida S; Selvaggi G; Tekin A; Moon J; Levi D; Woodle ES; Ruiz P; Weppler D; Lee OK; Tzakis AG
Transplantation; 2011 Sep; 92(6):709-15. PubMed ID: 21804443
[TBL] [Abstract][Full Text] [Related]
2. Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies.
Kubal C; Mangus R; Saxena R; Lobashevsky A; Higgins N; Fridell J; Tector AJ
Transplantation; 2015 Aug; 99(8):e49-56. PubMed ID: 25769071
[TBL] [Abstract][Full Text] [Related]
3. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation.
Caro-Oleas JL; González-Escribano MF; Gentil-Govantes MÁ; Acevedo MJ; González-Roncero FM; Blanco GB; Núñez-Roldán A
Transplantation; 2012 Aug; 94(4):338-44. PubMed ID: 22814330
[TBL] [Abstract][Full Text] [Related]
5. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
6. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N
Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
[TBL] [Abstract][Full Text] [Related]
7. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
[TBL] [Abstract][Full Text] [Related]
8. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
[TBL] [Abstract][Full Text] [Related]
9. Immediate antibody-mediated (hyperacute) rejection in small-bowel transplantation and relationship to cross-match status and donor-specific C4d-binding antibodies: case report.
Ruiz P; Carreno M; Weppler D; Gomez C; Island E; Selvaggi G; Nishida S; Moon J; Levi D; Tekin A; Tryphonopoulos P; Tzakis AG
Transplant Proc; 2010; 42(1):95-9. PubMed ID: 20172288
[TBL] [Abstract][Full Text] [Related]
10. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
11. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
12. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
Huang Y; Ramon D; Luan FL; Sung R; Samaniego M
Clin Transpl; 2012; ():247-56. PubMed ID: 23721029
[TBL] [Abstract][Full Text] [Related]
13. Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization.
Kato T; Mizutani K; Terasaki P; Quintini C; Selvaggi G; Thompson J; Ruiz P; Tzakis A
Transplant Proc; 2006; 38(6):1735-7. PubMed ID: 16908266
[TBL] [Abstract][Full Text] [Related]
14. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
Amico P; Hönger G; Bielmann D; Lutz D; Garzoni D; Steiger J; Mihatsch MJ; Dragun D; Schaub S
Transplantation; 2008 Jun; 85(11):1557-63. PubMed ID: 18551059
[TBL] [Abstract][Full Text] [Related]
15. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
Li X; Ishida H; Yamaguchi Y; Tanabe K
Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
[TBL] [Abstract][Full Text] [Related]
16. Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation.
Kobayashi T; Maruya E; Niwa M; Saji H; Kohara S; Katayama A; Takeda A; Watarai Y; Uchida K
Hum Immunol; 2011 Jan; 72(1):11-7. PubMed ID: 20974206
[TBL] [Abstract][Full Text] [Related]
17. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
Gibney EM; Cagle LR; Freed B; Warnell SE; Chan L; Wiseman AC
Nephrol Dial Transplant; 2006 Sep; 21(9):2625-9. PubMed ID: 16644776
[TBL] [Abstract][Full Text] [Related]
18. Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations.
Dieplinger G; Ditt V; Arns W; Huppertz A; Kisner T; Hellmich M; Bauerfeind U; Stippel DL
Transpl Int; 2014 Jan; 27(1):60-8. PubMed ID: 24131087
[TBL] [Abstract][Full Text] [Related]
19. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
Cheng EY; Kaneku H; Farmer DG
Clin Transpl; 2014; ():153-9. PubMed ID: 26281140
[TBL] [Abstract][Full Text] [Related]
20. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody.
Higgins R; Hathaway M; Lowe D; Lam F; Kashi H; Tan LC; Imray C; Fletcher S; Zehnder D; Chen K; Krishnan N; Hamer R; Briggs D
Transplantation; 2007 Oct; 84(7):876-84. PubMed ID: 17984841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
